| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Bicapital (BICA) | BofA Merrill Lynch/ Citigroup | $345.00 | n.a. | |||
| BJ Services (BJS) | Goldman Sachs/ Morgan Stanley/Credit Suisse | $100.00 | n.a. | |||
| I-AM Capital Acquisition (IAMU) (u) | Maxim Group LLC | 5.00 | $10.00 | $10.00 | $50.00 | n.a. |
| Torrid (CURV) | BofA Merrill Lynch/ Morgan Stanley/ Goldman Sachs/ J.P. Morgan/ Jefferies | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| CEBA Midstream, LP (CEBA) | Barclays/ RBC Capital Markets/ UBS Investment Bank | $100.00 | n.a. | |||
| Four Springs Capital Trust (FSPR) | RBC Capital Markets/ SunTrust Robinson Humphrey | 5.60 | $17.00 | $19.00 | $100.80 | 1-Star |
| New Terms | ||||||
| Calyxt (CLXT) | Citigroup/ Credit Suisse/ Jefferies | 6.06 | $15.00 | $18.00 | $100.00 | S/O |
| Kala Pharmaceuticals (KALA) | J.P. Morgan/ BofA Merrill Lynch | 6.00 | $14.00 | $16.00 | $90.00 | S/O |
| PetIQ (PETQ) | Jefferies/ William Blair | 5.67 | $14.00 | $16.00 | $85.00 | S/O |
| RBB Bancorp (RBB) | Sandler O’Neill/ Keefe, Bruyette & Woods (A Stifel Company)/ Stephens | 3.00 | $22.00 | $24.00 | $69.00 | S/O |
| TPG RE Finance Trust (TRTX) | BofA Merrill Lynch/ Citigroup/ Goldman, Sachs/ Wells Fargo Securities/ Deutsche Bank Securities/ Morgan Stanley/ Barclays | 11.00 | $20.00 | $21.00 | $225.50 | S/O |
| YogaWorks (YOGA) | Cowen/ Stephens/ Guggenheim Securities | 5.00 | $12.00 | $14.00 | $65.00 | S/O |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of July 10, 2017 | Manager(s) | Offered | Raised | Price | 7/14/17 | Change |
| Akcea Therapeutics (AKCA) | Cowen and Company/ Stifel/ Wells Fargo Securities | 15.63 | $125.00 | $8.00 | $9.48 | 18.50% |
| Co-Diagnostics (CODX) | WallachBeth Capital/ Network 1 Securities | 1.18 | $7.07 | $6.00 | $5.61 | -6.50% |
